Items where Author is "Riesen, W. F."
Number of items: 5. 2011Joerger, M. and Riesen, W. F. and Thürlimann, B.. (2011) Bevacizumab-associated hyperlipoproteinemia type IIb in a patient with advanced invasive-ductal breast cancer. Journal of oncology pharmacy practice, Vol. 17, H. 3. pp. 292-294. Joerger, M. and Templeton, A. and Köberle, D. and Engler, H. and Riesen, W. F. and Thürlimann, B.. (2011) Procollagen type I N-propeptide is a predictor of skeletal morbidity in patients with malignant osteolytic bone disease on bisphosphonates. Cancer chemotherapy and pharmacology, Vol. 67, H. 5. pp. 1137-1144. 1997Jeck, T. and Riesen, W. F. and Keller, U.. (1997) Comparison of bezafibrate and simvastatin in the treatment of dyslipidaemia in patients with NIDDM. Diabetic medicine, Vol. 14, H. 7. pp. 564-570. 1991Brocard, J. J. and Keller, U. and Oberhansli, A. and Riesen, W. F.. (1991) Wirkungen und Nebenwirkungen einer einjährigen Behandlung der primären Hypercholesterinämie mit Simvastatin. Schweizerische medizinische Wochenschrift, Jg. 121, H. 26. pp. 977-983. 1989Stohler, R. and Keller, U. and Riesen, W. F.. (1989) Effects of simvastatin and fenofibrate on serum lipoproteins and apolipoproteins in primary hypercholesterolaemia. European journal of clinical pharmacology, Vol. 37, H. 2. pp. 1-7. |
